Sweden · Delayed Price · Currency is SEK Egetis Therapeutics AB Statistics
Total Valuation
STO:EGTX has a market cap or net worth of SEK 3.67 billion. The enterprise value is 3.36 billion.
| Market Cap | 3.67B |
| Enterprise Value | 3.36B |
Important Dates
The last earnings date was Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:EGTX has 464.95 million shares outstanding. The number of shares has increased by 17.59% in one year.
| Current Share Class | 464.95M |
| Shares Outstanding | 464.95M |
| Shares Change (YoY) | +17.59% |
| Shares Change (QoQ) | +13.89% |
| Owned by Insiders (%) | 18.43% |
| Owned by Institutions (%) | 28.48% |
| Float | 240.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 491.13 |
| PS Ratio | 55.58 |
| PB Ratio | 7.62 |
| P/TBV Ratio | 7.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 50.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.14.
| Current Ratio | 1.49 |
| Quick Ratio | 1.46 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.23 |
| Interest Coverage | -38.52 |
Financial Efficiency
Return on equity (ROE) is -96.92% and return on invested capital (ROIC) is -48.53%.
| Return on Equity (ROE) | -96.92% |
| Return on Assets (ROA) | -34.38% |
| Return on Invested Capital (ROIC) | -48.53% |
| Return on Capital Employed (ROCE) | -78.80% |
| Weighted Average Cost of Capital (WACC) | 8.59% |
| Revenue Per Employee | 1.18M |
| Profits Per Employee | -7.24M |
| Employee Count | 56 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 39.29 |
Taxes
In the past 12 months, STO:EGTX has paid 400,000 in taxes.
| Income Tax | 400,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.14% in the last 52 weeks. The beta is 0.78, so STO:EGTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +49.14% |
| 50-Day Moving Average | 6.68 |
| 200-Day Moving Average | 5.69 |
| Relative Strength Index (RSI) | 64.48 |
| Average Volume (20 Days) | 873,052 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:EGTX had revenue of SEK 66.00 million and -405.40 million in losses. Loss per share was -1.01.
| Revenue | 66.00M |
| Gross Profit | 11.00M |
| Operating Income | -389.10M |
| Pretax Income | -405.00M |
| Net Income | -405.40M |
| EBITDA | -381.00M |
| EBIT | -389.10M |
| Loss Per Share | -1.01 |
Balance Sheet
The company has 378.40 million in cash and 68.80 million in debt, with a net cash position of 309.60 million or 0.67 per share.
| Cash & Cash Equivalents | 378.40M |
| Total Debt | 68.80M |
| Net Cash | 309.60M |
| Net Cash Per Share | 0.67 |
| Equity (Book Value) | 481.50M |
| Book Value Per Share | 1.04 |
| Working Capital | 130.00M |
Cash Flow
In the last 12 months, operating cash flow was -300.10 million and capital expenditures 500,000, giving a free cash flow of -299.60 million.
| Operating Cash Flow | -300.10M |
| Capital Expenditures | 500,000 |
| Depreciation & Amortization | 8.10M |
| Net Borrowing | -33.40M |
| Free Cash Flow | -299.60M |
| FCF Per Share | -0.64 |
Margins
| Gross Margin | 16.67% |
| Operating Margin | -589.55% |
| Pretax Margin | -613.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:EGTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.59% |
| Shareholder Yield | -17.59% |
| Earnings Yield | -11.05% |
| FCF Yield | -8.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for STO:EGTX is 15.33, which is 97.30% higher than the current price. The consensus rating is "Buy".
| Price Target | 15.33 |
| Price Target Difference | 97.30% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 145.83% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:EGTX has an Altman Z-Score of -0.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.74 |
| Piotroski F-Score | 3 |